SG43798A1 - Agonists and antagonistis of human interleukin-10 - Google Patents
Agonists and antagonistis of human interleukin-10Info
- Publication number
- SG43798A1 SG43798A1 SG1996000969A SG1996000969A SG43798A1 SG 43798 A1 SG43798 A1 SG 43798A1 SG 1996000969 A SG1996000969 A SG 1996000969A SG 1996000969 A SG1996000969 A SG 1996000969A SG 43798 A1 SG43798 A1 SG 43798A1
- Authority
- SG
- Singapore
- Prior art keywords
- antagonistis
- agonists
- human interleukin
- interleukin
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Wood Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9894393A | 1993-07-26 | 1993-07-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG43798A1 true SG43798A1 (en) | 1997-11-14 |
Family
ID=22271670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG1996000969A SG43798A1 (en) | 1993-07-26 | 1994-07-22 | Agonists and antagonistis of human interleukin-10 |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0711346A1 (en) |
| JP (1) | JPH08507930A (en) |
| KR (1) | KR960704041A (en) |
| CN (1) | CN1127529A (en) |
| AU (1) | AU681178B2 (en) |
| CA (1) | CA2168110A1 (en) |
| CZ (1) | CZ23396A3 (en) |
| FI (1) | FI960353A (en) |
| HU (1) | HUT73463A (en) |
| IL (1) | IL110413A0 (en) |
| NO (1) | NO960309D0 (en) |
| NZ (1) | NZ269663A (en) |
| PL (1) | PL312718A1 (en) |
| SG (1) | SG43798A1 (en) |
| SK (2) | SK150596A3 (en) |
| WO (1) | WO1995003411A1 (en) |
| ZA (1) | ZA945434B (en) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH10502249A (en) | 1994-07-05 | 1998-03-03 | スティーノ・リサーチ・グループ・アクティーゼルスカブ | Immunomodulator |
| GB2304047A (en) | 1995-08-09 | 1997-03-12 | Univ Manchester | Pharmaceutical compositions containing cytokines |
| AUPN481295A0 (en) * | 1995-08-16 | 1995-09-07 | Medvet Science Pty. Ltd. | Agonists of haemopoietic growth factors |
| WO1997026278A1 (en) | 1996-01-18 | 1997-07-24 | Steeno Research Group A/S | Synthetic il-10 analogues |
| DE19851675A1 (en) * | 1998-11-10 | 2000-05-11 | Bayer Ag | Human interleukin-10 mutant proteins |
| US6896885B2 (en) | 2000-03-31 | 2005-05-24 | Biogen Idec Inc. | Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| AU2001296962A1 (en) | 2000-09-29 | 2002-04-08 | Schering Corporation | Pegylated interleukin-10 |
| US7261882B2 (en) | 2003-06-23 | 2007-08-28 | Reagents Of The University Of Colorado | Methods for treating neuropathic pain by administering IL-10 polypeptides |
| EP1712241A1 (en) | 2005-04-15 | 2006-10-18 | Centre National De La Recherche Scientifique (Cnrs) | Composition for treating cancer adapted for intra-tumoral administration and uses thereof |
| EP2816118B1 (en) | 2005-05-31 | 2018-10-17 | The Regents of the University of Colorado, a body corporate | Methods for delivering genes |
| BRPI0719446A2 (en) | 2006-09-28 | 2013-12-10 | Schering Corp | Use of pegylated IL-10 to treat cancer |
| EP3281955A1 (en) | 2008-10-02 | 2018-02-14 | Aptevo Research and Development LLC | Cd86 antagonist multi-target binding proteins |
| JP5888980B2 (en) | 2008-12-17 | 2016-03-22 | メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． | Production and use of mono- and di-PEGIL10 |
| HUE038668T2 (en) | 2011-11-08 | 2018-11-28 | Umc Utrecht Holding Bv | Fusion protein comprising an interleukin 4 and interleukin 10 |
| CA2908198A1 (en) | 2013-04-18 | 2014-10-23 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| CA2908208A1 (en) * | 2013-04-24 | 2014-10-30 | Armo Biosciences, Inc. | Interleukin-10 compositions and uses thereof |
| US9823255B2 (en) | 2013-06-17 | 2017-11-21 | Armo Biosciences, Inc. | Method for assessing protein identity and stability |
| AU2014311432A1 (en) | 2013-08-30 | 2016-03-03 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| MX2016005915A (en) | 2013-11-11 | 2016-12-16 | Armo Biosciences Inc | Methods of using interleukin-10 for treating diseases and disorders. |
| CN106573072A (en) | 2014-06-02 | 2017-04-19 | 阿尔莫生物科技股份有限公司 | Methods of lowering serum cholesterol |
| CN107001438A (en) | 2014-10-14 | 2017-08-01 | 阿尔莫生物科技股份有限公司 | Interleukin 15 composition and application thereof |
| CN107106655A (en) | 2014-10-22 | 2017-08-29 | 阿尔莫生物科技股份有限公司 | The method that disease and illness are treated using interleukin 10 |
| US10618970B2 (en) | 2015-02-03 | 2020-04-14 | Armo Biosciences, Inc. | Method of treating cancer with IL-10 and antibodies that induce ADCC |
| EP3302547A1 (en) | 2015-05-28 | 2018-04-11 | Armo Biosciences, Inc. | Pegylated interleukin-10 for use in treating cancer |
| WO2017035232A1 (en) | 2015-08-25 | 2017-03-02 | Armo Biosciences, Inc. | Methods of using interleukin-10 for treating diseases and disorders |
| GB2620875B (en) | 2019-04-19 | 2024-05-08 | Synerkine Pharma B V | A fusion protein comprising IL13 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01113229A (en) * | 1987-10-27 | 1989-05-01 | Inahata Kenkyusho:Kk | Porous material of honeycomb structure |
| IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
| ATE187336T1 (en) * | 1991-08-06 | 1999-12-15 | Schering Corp | USE OF INTERLEUKIN-10 ANALOGUE OR ANTAGONIST FOR THE TREATMENT OF ENDOTOXIN OR SUPERANTIGEN INDUCED TOXICITY |
-
1994
- 1994-07-22 WO PCT/US1994/008052 patent/WO1995003411A1/en not_active Application Discontinuation
- 1994-07-22 SG SG1996000969A patent/SG43798A1/en unknown
- 1994-07-22 JP JP7505238A patent/JPH08507930A/en active Pending
- 1994-07-22 EP EP94923956A patent/EP0711346A1/en not_active Withdrawn
- 1994-07-22 NZ NZ269663A patent/NZ269663A/en unknown
- 1994-07-22 HU HU9503983A patent/HUT73463A/en unknown
- 1994-07-22 SK SK1505-96A patent/SK150596A3/en unknown
- 1994-07-22 CZ CZ96233A patent/CZ23396A3/en unknown
- 1994-07-22 SK SK83-96A patent/SK8396A3/en unknown
- 1994-07-22 PL PL94312718A patent/PL312718A1/en unknown
- 1994-07-22 KR KR1019960700358A patent/KR960704041A/en not_active Application Discontinuation
- 1994-07-22 IL IL11041394A patent/IL110413A0/en unknown
- 1994-07-22 CA CA002168110A patent/CA2168110A1/en not_active Abandoned
- 1994-07-22 AU AU73996/94A patent/AU681178B2/en not_active Ceased
- 1994-07-22 CN CN94192880A patent/CN1127529A/en active Pending
- 1994-07-22 ZA ZA945434A patent/ZA945434B/en unknown
-
1996
- 1996-01-25 NO NO960309A patent/NO960309D0/en unknown
- 1996-01-26 FI FI960353A patent/FI960353A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK8396A3 (en) | 1997-03-05 |
| CN1127529A (en) | 1996-07-24 |
| CA2168110A1 (en) | 1995-02-02 |
| KR960704041A (en) | 1996-08-31 |
| FI960353A0 (en) | 1996-01-26 |
| EP0711346A1 (en) | 1996-05-15 |
| NO960309L (en) | 1996-01-25 |
| NO960309D0 (en) | 1996-01-25 |
| HU9503983D0 (en) | 1996-03-28 |
| CZ23396A3 (en) | 1996-05-15 |
| FI960353A (en) | 1996-01-26 |
| JPH08507930A (en) | 1996-08-27 |
| SK150596A3 (en) | 1997-04-09 |
| AU7399694A (en) | 1995-02-20 |
| HUT73463A (en) | 1996-08-28 |
| NZ269663A (en) | 1997-09-22 |
| AU681178B2 (en) | 1997-08-21 |
| IL110413A0 (en) | 1994-10-21 |
| PL312718A1 (en) | 1996-05-13 |
| WO1995003411A1 (en) | 1995-02-02 |
| ZA945434B (en) | 1995-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG43798A1 (en) | Agonists and antagonistis of human interleukin-10 | |
| GB9214857D0 (en) | Human nucleic acid fragments and their use | |
| GB9300213D0 (en) | Wrist and hand support | |
| EP0880356A4 (en) | Antimicrobial peptides and methods of use | |
| GB2277826B (en) | Surgical and/or clinical apparatus | |
| HUT73102A (en) | Purification of human interleukin-10 | |
| HU9403655D0 (en) | Methods of inhibiting atrophy of the skin and vagina | |
| EP0586687A4 (en) | Trans-sialidase and methods of use and making thereof | |
| IL114331A0 (en) | Medical use of bromelain | |
| HU9600241D0 (en) | Mutable composition and methods of use thereof | |
| HU9402361D0 (en) | New makrolides and use of them | |
| AP9300555A0 (en) | Therapeutic agent and its use | |
| ZA899778B (en) | Reduction of piperidine-dion-derivatives and intermediates | |
| GB9313188D0 (en) | Medical use of enzymes | |
| HUP9800146A3 (en) | Thalidomide-derivatives and use of them | |
| GB2294637B (en) | Therapeutic compositions and methods of use | |
| GB2240310B (en) | Double acting switch and method of use | |
| GB2275314B (en) | Support member and method of use | |
| EP1015559A4 (en) | Human regeneration-associated serpin-1 (rasp-1) and methods of use | |
| GB9318480D0 (en) | Briquette and preparation of same | |
| GB9312030D0 (en) | Preparation and use of lipo-n-acetyl-cysteine | |
| GB9308018D0 (en) | Connecting means and method of use thereof | |
| GB9213862D0 (en) | Medical use of enzymes | |
| GB9318914D0 (en) | Preparation of fluoro-nucleosides and intermediates for use therein | |
| GB9308164D0 (en) | Medical use of enzymes |